A detailed history of State Of Wisconsin Investment Board transactions in Moon Lake Immunotherapeutics stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 13,029 shares of MLTX stock, worth $679,722. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,029
Previous 12,556 3.77%
Holding current value
$679,722
Previous $552,000 18.84%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$40.15 - $55.4 $18,990 - $26,204
473 Added 3.77%
13,029 $656,000
Q2 2024

Aug 14, 2024

SELL
$38.43 - $48.6 $31,820 - $40,240
-828 Reduced 6.19%
12,556 $552,000
Q1 2024

May 14, 2024

SELL
$43.78 - $63.86 $74,951 - $109,328
-1,712 Reduced 11.34%
13,384 $672,000
Q4 2023

Feb 12, 2024

SELL
$36.35 - $63.02 $18,683 - $32,392
-514 Reduced 3.29%
15,096 $911,000
Q3 2023

Nov 14, 2023

BUY
$48.35 - $61.26 $754,743 - $956,268
15,610 New
15,610 $889,000

Others Institutions Holding MLTX

About MoonLake Immunotherapeutics


  • Ticker MLTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,925,600
  • Market Cap $1.93B
  • Description
  • MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...
More about MLTX
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.